A

Acceleris Capital

6 employees

Acceleris Capital provides corporate finance advice and raises funds for early and development stage businesses.

Investor insights

Sectors invested in

Biotechnology5
Chemical4
Farming3
Agriculture3
Medical2
Pharmaceutical2
PELVIVA1
Pharmaceuticals1
Commercialising sulforaphane-based pharmaceuticals1
Cancer and neurological conditions1
Core technology Sulforadex®1
air pollution1
health1
Research1
digital health1
vertical farming1
economic analysis1
technology1
environment1
womens Health1

Funding rounds participated in

$2M sweet spot round size

Most of their 12 investments are in rounds between $2M and $4M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Corporate Finance
Financial Services
Fund Raising
Finance
Advisory
Venture Capital

Date founded

2000

Investments made

U

Undisclosed raised $4.2M on February 19, 2021

Investors: RAB Capital Plc, Indigo 7 Ventures, Kero Development Partners and Acceleris Capital

U

Undisclosed raised $1.6M on April 21, 2020

Investors: Development Bank of Wales and Acceleris Capital

V

Vertical Future raised $4.9M on October 8, 2019

Investors: Earthworm Group and Acceleris Capital

R

Redag Crop Protection raised $2M on September 19, 2017

Investors: Seneca Partners and Acceleris Capital

A

Apex Molecular Ltd raised undisclosed on October 6, 2016

Investors: Greater Manchester and Cheshire Life Sciences Fund, Seneca Partners Limited and Acceleris Capital

R

Redag Crop Protection raised $2M on March 3, 2016

Investors: Seneca Partners and Acceleris Capital

E

Evgen Pharma raised $2M on September 10, 2015

Investors: Seneca Partners and Acceleris Capital

U

Undisclosed raised undisclosed on January 1, 2015

Investors: Acceleris Capital

R

Redag Crop Protection raised undisclosed on October 24, 2014

Investors: Acceleris Capital

U

Undisclosed raised undisclosed on February 1, 2014

Investors: Acceleris Capital

FAQ